Nexgel Inc (NXGL) Stock Price, Quote & News

Company Profile

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 215 702 8550

Website: nexgel.com

Address:

2150 Cabot Boulevard West, Suite B, Langhorne, United States

topstockalerts Jul. 2 at 12:15 PM

$NXGL are we having fun team??

0 · Reply

topstockalerts Jul. 2 at 11:49 AM

$NXGL fresh alert wants to breakout 💵💵💵💵

0 · Reply

topstockalerts Jul. 2 at 1:36 AM

$NXGL alert was sent this morning 🚨🔥💵🍾 Congrats 🍾 Stay tuned for what we got coming next!

0 · Reply

topstockalerts Jul. 1 at 7:57 PM

$NXGL are we having fun???

0 · Reply

topstockalerts Jul. 1 at 7:30 PM

$NXGL fresh alert sent today and it’s printing for us!! This is what we do!! 💵💵💵💵💵👏 We’re already researching the next play. Are you gonna be in?

0 · Reply

topstockalerts Jul. 1 at 7:09 PM

$NXGL alerted yesterday and we are banking 🏦 Let’s go team!!! 💵💵💵💵💵💵💵💵

1 · Reply

topstockalerts Jul. 1 at 6:12 PM

$NXGL what a day 💵💵💵💵💵💵👏

0 · Reply

topstockalerts Jul. 1 at 5:49 PM

$NXGL alerted today for a big profit 🔥💵🍾

0 · Reply

topstockalerts Jul. 1 at 5:48 PM

$NXGL amazing run!!! 👏👏👏👏

0 · Reply

topstockalerts Jul. 1 at 5:10 PM

$NXGL fresh alerts are paying us today!! Congrats team! 👏👏👏👏

0 · Reply

NEXGEL Slides: Investor presentation

Jun 17, 2026, 4:30 PM EDT - 17 days ago

NEXGEL Transcript: Planet MicroCap Las Vegas 2026

Jun 9, 2026, 8:00 AM EDT - 25 days ago

NEXGEL Proxy statement: Proxy filing

Jun 4, 2026, 9:00 AM EDT - 4 weeks ago

NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th

NXGLW

May 29, 2026, 8:00 AM EDT - 5 weeks ago

NEXGEL Proxy statement: Proxy filing

2026-05-19T13:23:14.000Z - 6 weeks ago

NexGel announces data from institutional review board clinical study

May 19, 2026, 9:00 AM EDT - 6 weeks ago

NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration

NXGLW

May 15, 2026, 12:00 PM EDT - 7 weeks ago

NEXGEL Earnings Call Transcript: Q1 2026

May 15, 2026, 12:00 PM EDT - 7 weeks ago

NEXGEL Quarterly report: Q1 2026

May 13, 2026, 8:30 AM EDT - 7 weeks ago

NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical

NXGLW

May 12, 2026, 10:27 AM EDT - 7 weeks ago

NEXGEL To Report First Quarter 2026 Financial Results on May 15th

NXGLW

May 6, 2026, 9:00 AM EDT - 2 months ago

NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors

NXGLW

2026-04-27T13:38:27.000Z - 2 months ago

NexGel appoints Ian Blackman as CFO

CELU

Apr 21, 2026, 4:30 PM EDT - 2 months ago

NEXGEL Transcript: M&A announcement

Apr 21, 2026, 4:30 PM EDT - 2 months ago

NEXGEL Press release: M&A announcement

2026-04-21T15:06:20.000Z - 2 months ago

NexGel closes acquisition of products from Celularity

CELU

Apr 17, 2026, 3:37 PM EDT - 2 months ago

NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

Apr 15, 2026, 4:12 PM EDT - 2 months ago

NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction

Apr 8, 2026, 4:05 PM EDT - 3 months ago

NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction

Mar 31, 2026, 4:12 PM EDT - 3 months ago

NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity

Mar 31, 2026, 7:00 AM EDT - 3 months ago

NEXGEL Annual report: Q4 2025

2026-03-12T13:15:47.000Z - 4 months ago

NexGel price target lowered to $2 from $6 at Maxim

2026-03-12T12:55:45.000Z - 4 months ago

NexGel announces terms of agreement of license for products from Celularity

CELU

Mar 12, 2026, 8:45 AM EDT - 4 months ago

NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products

2026-03-12T12:35:15.000Z - 4 months ago

Celularity reiterates strategic commercialization partnership with NEXGEL

CELU

2026-03-10T12:51:55.000Z - 4 months ago

NexGel sign agreement to license, acquire portfolio of products from Celularity

CELU

Mar 10, 2026, 8:45 AM EDT - 4 months ago

NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products

2026-02-10T14:10:54.000Z - 5 months ago

NexGel announces financing of $1.797M relating to acquistion

2025-12-16T13:10:10.000Z - 7 months ago

NexGelRx receives additional investment from Eric Gruntfest, Ariel Imas

2025-12-11T13:15:18.000Z - 7 months ago

NexGel to spin-off drug delivery program into NexGelRx

Dec 11, 2025, 8:00 AM EST - 7 months ago

NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx

Nov 11, 2025, 4:30 PM EST - 8 months ago

NEXGEL Earnings Call Transcript: Q3 2025

Nov 11, 2025, 4:30 PM EST - 8 months ago

NEXGEL Quarterly report: Q3 2025

Nov 11, 2025, 4:30 PM EST - 8 months ago

NEXGEL Earnings release: Q3 2025

Nov 11, 2025, 4:10 PM EST - 8 months ago

NEXGEL Reports Third Quarter 2025 Financial Results

Oct 30, 2025, 8:00 AM EDT - 8 months ago

NEXGEL Proxy statement: Proxy Filing

Oct 20, 2025, 2:30 PM EDT - 9 months ago

NEXGEL Transcript: LD Micro Main Event XIX Investor Conference

Oct 20, 2025, 8:00 AM EDT - 9 months ago

NEXGEL Proxy statement: Proxy Filing

Aug 12, 2025, 4:30 PM EDT - 11 months ago

NEXGEL Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

NEXGEL Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

NEXGEL Earnings release: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 11 months ago

NEXGEL Slides: Investor Presentation

Aug 6, 2025, 8:00 AM EDT - 11 months ago

NEXGEL to Report Second Quarter 2025 Financial Results on August 12th

2025-08-05T12:29:27.000Z - 11 months ago

NexGel appoints Steve Ciardiello to board of directors

SSTK

2025-08-01T12:05:29.000Z - 1 year ago

NexGel prices 413,044 shares at $2.30 in registered direct offering

Aug 1, 2025, 8:00 AM EDT - 1 year ago

NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement

2025-07-14T13:05:37.000Z - 1 year ago

NexGel, STADA announce expansion of partnership for North America

Jul 14, 2025, 9:00 AM EDT - 1 year ago

NEXGEL and STADA AG Announce Expansion of Partnership for North America

May 13, 2025, 4:30 PM EDT - 1 year ago

NEXGEL Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

NEXGEL Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

NEXGEL Earnings release: Q1 2025

May 9, 2025, 9:00 AM EDT - 1 year ago

NEXGEL to Report First Quarter 2025 Financial Results on May 13th

Apr 30, 2025, 8:00 AM EDT - 1 year ago

NEXGEL Proxy statement: Proxy Filing

Apr 23, 2025, 12:30 PM EDT - 1 year ago

NEXGEL Transcript: Planet MicroCap Showcase: VEGAS 2025

Mar 24, 2025, 4:30 PM EDT - 1 year ago

NEXGEL Earnings Call Transcript: Q4 2024

Mar 24, 2025, 4:30 PM EDT - 1 year ago

NEXGEL Annual report: Q4 2024

Mar 24, 2025, 4:30 PM EDT - 1 year ago

NEXGEL Earnings release: Q4 2024

Mar 24, 2025, 4:05 PM EDT - 1 year ago

NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results

Mar 19, 2025, 9:00 AM EDT - 1 year ago

NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th

Feb 13, 2025, 9:00 AM EST - 1 year ago

NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025

2025-01-22T14:10:46.000Z - 1 year ago

NexGel expects to generate at least $13M in revenue in FY25

2025-01-22T14:05:27.000Z - 1 year ago

NexGel issues letter to shareholders

2025-01-22T14:05:10.000Z - 1 year ago

NexGel sees Q4 revenue approximately $3M

2025-01-02T14:05:24.000Z - 1 year ago

NexGel appoints McGuire as Chief Financial Officer

Jan 2, 2025, 9:00 AM EST - 1 year ago

NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer

Dec 10, 2024, 10:30 AM EST - 1 year ago

NEXGEL Transcript: IAccess Alpha–Buyside Best Ideas Winter Virtual Conference 2024

Nov 13, 2024, 4:40 PM EST - 1 year ago

NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially

Nov 13, 2024, 4:30 PM EST - 1 year ago

NEXGEL Earnings Call Transcript: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

NEXGEL Earnings release: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

NEXGEL Quarterly report: Q3 2024

2024-11-11T22:45:07.000Z - 1 year ago

NexGel announces $2M registered direct offering

Nov 11, 2024, 5:35 PM EST - 1 year ago

NEXGEL Announces $2,000,000 Registered Direct Offering

Oct 11, 2024, 9:00 AM EDT - 1 year ago

NEXGEL to Participate in Upcoming October Investor Conferences

2024-10-10T13:05:57.000Z - 1 year ago

NexGel expects Q3 revenue approx $2.85M

Oct 4, 2024, 9:00 AM EDT - 1 year ago

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

Aug 14, 2024, 4:30 PM EDT - 2 years ago

NEXGEL Earnings Call Transcript: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

NEXGEL Quarterly report: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

NEXGEL Earnings release: Q2 2024

Aug 14, 2024, 4:25 PM EDT - 2 years ago

NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million

Aug 12, 2024, 9:15 AM EDT - 2 years ago

NEXGEL to Report Second Quarter 2024 Financial Results on August 14th

Jul 18, 2024, 9:15 AM EDT - 2 years ago

NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal

Jul 8, 2024, 4:05 PM EDT - 2 years ago

NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively

Jun 11, 2024, 8:40 AM EDT - 2 years ago

NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America

May 16, 2024, 9:00 AM EDT - 2 years ago

NEXGEL Acquires International Beauty Brand, Silly George

May 13, 2024, 4:30 PM EDT - 2 years ago

NEXGEL Earnings Call Transcript: Q1 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

NEXGEL Quarterly report: Q1 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

NEXGEL Earnings release: Q1 2024

May 3, 2024, 8:00 AM EDT - 2 years ago

NEXGEL Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

NEXGEL Proxy statement: Proxy Filing

Apr 1, 2024, 8:30 AM EDT - 2 years ago

NEXGEL Earnings Call Transcript: Q4 2023

Apr 1, 2024, 8:30 AM EDT - 2 years ago

NEXGEL Earnings release: Q4 2023

Apr 1, 2024, 8:30 AM EDT - 2 years ago

NEXGEL Annual report: Q4 2023

Apr 1, 2024, 7:50 AM EDT - 2 years ago

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

Mar 27, 2024, 9:00 AM EDT - 2 years ago

NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday

Mar 21, 2024, 9:00 AM EDT - 2 years ago

NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th

Mar 12, 2024, 1:30 PM EDT - 2 years ago

NEXGEL Transcript: iAccess Alpha Best Ideas Spring Virtual Conference

Mar 4, 2024, 8:30 AM EST - 2 years ago

NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

Jan 9, 2024, 8:30 AM EST - 2 years ago

NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024

Dec 11, 2023, 8:00 AM EST - 2 years ago

NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America

Nov 13, 2023, 4:30 PM EST - 2 years ago

NEXGEL Earnings Call Transcript: Q3 2023

Nov 13, 2023, 4:30 PM EST - 2 years ago

NEXGEL Quarterly report: Q3 2023

Nov 13, 2023, 4:30 PM EST - 2 years ago

NEXGEL Earnings release: Q3 2023

Nov 13, 2023, 4:05 PM EST - 2 years ago

NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year

Sep 26, 2023, 9:49 AM EDT - 3 years ago

NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd

Aug 14, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Earnings Call Transcript: Q2 2023

Aug 14, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Quarterly report: Q2 2023

Aug 14, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Earnings release: Q2 2023

Aug 2, 2023, 9:00 AM EDT - 3 years ago

NEXGEL to Report Second Quarter 2023 Financial Results on August 14th

Jul 19, 2023, 9:10 AM EDT - 3 years ago

NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North America

Jun 15, 2023, 9:00 AM EDT - 3 years ago

NEXGEL to Participate in Maxim Group's Virtual Healthcare Conference on June 20th

May 26, 2023, 8:00 AM EDT - 3 years ago

NEXGEL Registration statement: Registration Filing

May 24, 2023, 9:00 AM EDT - 3 years ago

NEXGEL to Participate in the LD Micro Invitational XIII on June 6th

May 15, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Earnings Call Transcript: Q1 2023

May 15, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Quarterly report: Q1 2023

May 15, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Earnings release: Q1 2023

May 9, 2023, 9:15 AM EDT - 3 years ago

NEXGEL to Report First Quarter 2023 Financial Results on May 15th

Apr 27, 2023, 8:00 AM EDT - 3 years ago

NEXGEL Proxy statement: Proxy Filing

Mar 27, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Earnings Call Transcript: Q4 2022

Mar 27, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Earnings release: Q4 2022

Mar 27, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Annual report: Q4 2022

Mar 27, 2023, 4:05 PM EDT - 3 years ago

NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 15, 2023, 7:30 AM EDT - 3 years ago

NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th

Mar 7, 2023, 7:30 AM EST - 3 years ago

NEXGEL Partners with Former Major League Lacrosse Player, Greg “The Beast” Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard

Mar 2, 2023, 8:30 AM EST - 3 years ago

NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business

Jan 17, 2023, 7:30 AM EST - 3 years ago

NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee

Dec 8, 2022, 7:30 AM EST - 3 years ago

NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds

topstockalerts Jul. 2 at 12:15 PM

$NXGL are we having fun team??

0 · Reply

topstockalerts Jul. 2 at 11:49 AM

$NXGL fresh alert wants to breakout 💵💵💵💵

0 · Reply

topstockalerts Jul. 2 at 1:36 AM

$NXGL alert was sent this morning 🚨🔥💵🍾 Congrats 🍾 Stay tuned for what we got coming next!

0 · Reply

topstockalerts Jul. 1 at 7:57 PM

$NXGL are we having fun???

0 · Reply

topstockalerts Jul. 1 at 7:30 PM

$NXGL fresh alert sent today and it’s printing for us!! This is what we do!! 💵💵💵💵💵👏 We’re already researching the next play. Are you gonna be in?

0 · Reply

topstockalerts Jul. 1 at 7:09 PM

$NXGL alerted yesterday and we are banking 🏦 Let’s go team!!! 💵💵💵💵💵💵💵💵

1 · Reply

topstockalerts Jul. 1 at 6:12 PM

$NXGL what a day 💵💵💵💵💵💵👏

0 · Reply

topstockalerts Jul. 1 at 5:49 PM

$NXGL alerted today for a big profit 🔥💵🍾

0 · Reply

topstockalerts Jul. 1 at 5:48 PM

$NXGL amazing run!!! 👏👏👏👏

0 · Reply

topstockalerts Jul. 1 at 5:10 PM

$NXGL fresh alerts are paying us today!! Congrats team! 👏👏👏👏

0 · Reply

topstockalerts Jul. 1 at 5:06 PM

$NXGL alert was sent this morning 🚨🔥💵🍾 Congrats 🍾 Stay tuned for what we got coming next!!

0 · Reply

topstockalerts Jul. 1 at 4:44 PM

$NXGL alerted today to the team! 💵💵💵💵💵 Congrats to all making bank!!

0 · Reply

topstockalerts Jul. 1 at 4:41 PM

$NXGL let’s go team!!! 💵💵💵💵💵💵💵💵👏

0 · Reply

topstockalerts Jul. 1 at 3:38 PM

$NXGL alerted today and it’s already breaking out!! Let’s go team! 💵💵💵💵👏

0 · Reply

LeverUp19 Jul. 1 at 2:37 PM

$NXGL Good bit of volume this morning. Looking forward to Adam's Q2 report next month!

0 · Reply

topstockalerts Jul. 1 at 2:06 PM

$NXGL send it 🚀🚀🚀

0 · Reply

Biocuda Jun. 30 at 10:55 PM

$NXGL how does it hit .4128 when there are bids at .50+

0 · Reply

BigBoyTroy Jun. 29 at 9:55 PM

$NXGL bought that dip in the 0.49 area thank you shorts 🩳 Free discord link in my stoctwits Profile my bullish 🐂 peeps

0 · Reply

Luka_Brasi Jun. 27 at 11:50 PM

$NXGL It was hot out today and I was thinking how nice it would be to have a watermelon flavored frozen jelly water.

0 · Reply

BigBoyTroy Jun. 24 at 10:36 PM

$NXGL Free discord link in my stoctwits Profile NXGL support and resistance levels $0.55 – $0.557 → current micro-support VWAP pivot $0.53 – $0.54 → next bounce zone if it dips $0.50 – $0.52 → major structural support $0.48 – $0.49 → breakdown floor last real safety net :red_circle: Resistance $0.58 – $0.60 $0.63 – $0.66 → major resistance wall (where prior momentum failed) $0.70 → trend breakout level needs real volume

0 · Reply

luckydog2 Jun. 24 at 4:30 PM

$NXGL Great product feedback...I love when a product works well! https://www.reddit.com/r/NXGL/s/0vSDKhzMx7

1 · Reply

LeverUp19 Jun. 24 at 3:23 PM

$NXGL Wonder if the higher volume combined with suppressed share price is the result of certain debt holders choosing to convert. Suppose it could also be some of the new salespeople buying in, but i would think that would be pushing the price up. Here's hoping Adam has got some good news for us in August. A reverse split would not be encouraging at this point.

0 · Reply

Market Cap	5.21M
Revenue (ttm)	11.42M
Net Income (ttm)	-3.00M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-26.27%
Debt to Equity Ratio	0.00

Volume	286,200
Avg Vol	305,992
Day's Range	N/A - N/A
Shares Out	9.23M
Stochastic %K	57%
Beta	0.76
Analysts	Strong Sell
Price Target	$2.00